🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The selection of the optimal antithrombotic therapy in patients with nonval...
Status
Completed
Location
Medizinische Universität Innsbruck Universitätsklinik für Innere Medizin III - Kardiologie und Angiologie Anichstraße 35 6020 Innsbruck, Austria
Start Date
2021-12-16
Trial ID
NCT04981041
Treatments Being Tested
The study compares two lengths of medication therapy (a shortened versus a ...
Status
Completed
Location
Buenos Aires Research center
Start Date
2017-04-04
Trial ID
NCT03023020
Treatments Being Tested
This is a multicenter, open-label, randomized controlled study meant to com...
Status
Unknown
Location
Fuwai Hospital, National Center for Cardiovascular Diseases，Chinese Academy of Medical Sciences
Start Date
2023-10-15
Trial ID
NCT06084000
This Phase IV, multicenter trial is designed to assess the efficacy of pras...
Status
Completed
Location
Kaohsiung Veterans General Hospital
Start Date
2018-10-16
Trial ID
NCT03672097
Treatments Being Tested
Nondisabling cerebrovascular events represent the largest group of cerebrov...
Status
Unknown
Location
Xijing Hospital
Start Date
2014-01
Trial ID
NCT01924325
Treatments Being Tested
This study aims to compare the outcome between genotype guided versus clini...
Status
Completed
Location
Department of Medicine, the University of Hong Kong, Queen Mary Hospital, Hospital Authority
Start Date
2013-08
Trial ID
NCT01994941
Treatments Being Tested
The new P2Y12 inhibitors prasugrel (Efient®-Effient®) and ticagrelor (Brili...
Status
Completed
Location
Institut de Cardiologie - USIC - Hôpital Pitié-Salpêtrière
Start Date
2017-01-09
Trial ID
NCT02617290
Treatments Being Tested
Primary percutaneous coronary intervention (PCI) is the preferred revascula...
Status
Recruiting
Location
Geneva University Hospitals
Start Date
2025-11-01
Trial ID
NCT05785897
Ticagrelor, a direct-acting oral P2Y12-receptor antagonist, provides greate...
Status
Unknown
Location
Severance Hospital, Yonsei University Health System
Start Date
2022-02-01
Trial ID
NCT05166538
Treatments Being Tested
Atrial fibrillation (AF) coincides with coronary artery disease (CAD) share...
Status
Recruiting
Location
Ling Tao
Start Date
2022-09-01
Trial ID
NCT05353140
Treatments Being Tested